Companies

Search, filter and compare every US company we cover.

Search companies

Sector

Industry

Size

Today

Profitable Growing

Add filter

Clear all

Revenue growth

Min % Max %

935 companies match

Sort by

Market cap

Highest first

Company	Industry	Market cap	Price	Day change	Revenue	Revenue growth	Operating margin	P/E	5-yr growth	Gross margin	Net margin	Free cash flow	FCF margin	Return on capital	Return on equity	Net debt	Net debt / EBITDA	Dividends + buybacks	Share count change	F-score	Insider buys (90d)	Insider sales (90d)
GrindrGRND	Interactive Media & Services	$2.3B	$12.94	1.4%	$440M	27.6%	28.7%	25.9x	—	—	21.5%	$141M	32.0%	44.3%	—	$309M	2.3x	$451M	11.0%	6	$0.0M	$24.1M
Flywire CorpFLYW	Services-Business Services, Nec	$2.3B	$18.84	1.6%	$623M	26.6%	1.8%	69.8x	36.4%	—	2.2%	$98.8M	15.9%	—	1.6%	—	—	—	−1.2%	6	$0.0M	$14.8M
Aurinia Pharmaceuticals Inc.AUPH	Pharmaceutical Preparations	$2.3B	$17.25	1.2%	$283M	20.4%	37.1%	7.5x	41.4%	88.5%	101.5%	—	—	—	59.9%	—	—	$98.2M	−5.1%	6	$0.0M	$0.5M
Encore Capital Group IncECPG	Short-Term Business Credit Institutions	$2.3B	$99.46	0.2%	$1.8B	34.4%	35.4%	7.6x	3.3%	—	14.5%	$127M	7.2%	9.9%	29.5%	$3.9B	5.9x	$90.4M	−1.4%	6	$0.0M	$0.0M
Agios Pharmaceuticals, Inc.AGIO	Pharmaceutical Preparations	$2.3B	$38.03	3.2%	$54.0M	48.0%	−873.9%	—	—	88.3%	−764.0%	−$377M	−698.3%	—	−30.2%	—	—	—	0.1%	2	$0.0M	$1.0M
Addus HomeCareADUS	Health Care Services	$2.2B	$121.24	0.1%	$1.4B	23.2%	9.7%	21.2x	13.2%	32.5%	6.7%	$104M	7.3%	9.4%	9.3%	$39.4M	0.3x	$0.0M	5.8%	5	$0.0M	$0.0M
Ltc Properties IncLTC	Real Estate Investment Trusts	$2.2B	$42.91	2.4%	$263M	25.3%	77.9%	15.4x	10.5%	—	44.9%	—	—	10.7%	11.6%	$828M	3.4x	$107M	5.2%	5	$0.2M	$0.0M
Harmony BiosciencesHRMY	Biotechnology	$2.2B	$37.95	3.0%	$869M	21.5%	24.0%	12.3x	40.3%	77.2%	18.3%	$348M	40.1%	48.9%	20.8%	−$612M	—	$0.0M	1.2%	5	$0.0M	$3.1M
Ceco Environmental CorpCECO	Industrial & Commercial Fans & Blowers & Air Purifing Equip	$2.2B	$50.15	4.9%	$774M	38.8%	13.7%	—	19.6%	34.8%	6.5%	−$5.5M	−0.7%	13.8%	17.7%	$179M	1.4x	$0.0M	0.6%	5	$0.0M	$0.0M
Nlight, Inc.LASR	Semiconductors & Related Devices	$2.2B	$38.07	3.7%	$261M	31.6%	−10.2%	—	3.2%	29.8%	−9.0%	$12.3M	4.7%	—	−10.6%	—	—	—	4.3%	5	$0.0M	$27.2M
Ouster, Inc.OUST	General Industrial Machinery & Equipment, Nec	$2.2B	$32.79	10.4%	$169M	52.5%	−43.7%	—	55.0%	49.3%	−35.6%	−$64.8M	−38.3%	—	−27.3%	—	—	—	20.9%	5	$0.0M	$6.7M
Innovex InternationalINVX	Oil & Gas Equipment & Services	$2.2B	$31.13	1.5%	$978M	48.0%	13.6%	35.0x	21.8%	31.0%	8.5%	—	—	—	8.3%	−$178M	−0.9x	$9.3M	37.0%	5	$0.0M	$287M
Recursion Pharmaceuticals, Inc.RXRX	Biological Products, (No Diagnostic Substances)	$2.2B	$4.05	6.6%	$74.7M	26.9%	−867.9%	—	79.9%	5.0%	−863.4%	−$378M	−506.5%	−126.0%	−59.5%	−$706M	—	—	63.2%	4	$0.0M	$0.6M
Biocryst Pharmaceuticals IncBCRX	Biological Products, (No Diagnostic Substances)	$2.1B	$8.10	2.8%	$875M	94.1%	39.0%	—	117.9%	97.8%	30.2%	$345M	39.4%	—	—	−$272M	−0.8x	—	5.8%	7	$0.0M	$0.0M
Bancorp, Inc.TBBK	National Commercial Banks	$2.1B	$51.03	0.4%	$141M	20.8%	—	9.6x	81.8%	—	161.7%	$258M	182.7%	—	30.8%	$86.4M	—	$378M	−8.5%	5	$0.0M	$0.2M
Zymeworks Inc.ZYME	Pharmaceutical Preparations	$2.1B	$28.85	1.7%	$106M	38.9%	−87.3%	—	22.2%	—	−76.6%	−$34.5M	−32.6%	—	−26.7%	—	—	$41.7M	−0.6%	5	$0.0M	$0.4M
Sunrun Inc.RUN	Construction - Special Trade Contractors	$2.1B	$7.53	3.6%	$3.0B	45.1%	−4.3%	5.1x	26.2%	—	15.2%	—	—	−0.6%	15.8%	$13.5B	—	—	19.0%	4	$0.0M	$1.0M
Perdoceo EducationPRDO	Education Services	$2.0B	$32.23	1.5%	$846M	24.2%	23.2%	11.7x	4.2%	—	18.9%	$217M	25.6%	—	16.6%	—	—	$121M	−1.6%	—	$0.0M	$1.9M
Schrodinger, Inc.SDGR	Pharmaceutical Preparations	$2.0B	$26.72	9.1%	$256M	23.3%	−65.2%	—	18.8%	55.7%	−40.4%	$12.5M	4.9%	—	−26.3%	—	—	—	1.1%	4	$0.0M	$0.9M
Establishment Labs Holdings Inc.ESTA	Orthopedic, Prosthetic & Surgical Appliances & Supplies	$2.0B	$66.95	1.8%	$211M	27.1%	−18.5%	—	20.0%	69.3%	−24.2%	−$56.9M	−27.0%	−15.8%	−133.3%	$172M	—	—	5.2%	4	$0.0M	$0.0M
Axogen, Inc.AXGN	Electromedical & Electrotherapeutic Apparatus	$2.0B	$37.46	1.5%	$225M	20.2%	−3.5%	—	14.9%	74.3%	−7.0%	−$2.9M	−1.3%	−4.6%	−13.5%	$6.9M	—	—	4.1%	5	$0.0M	$4.7M
Karooooo Ltd.KARO	Services-Prepackaged Software	$2.0B	$64.46	0.4%	$313M	25.4%	25.8%	35.0x	17.7%	68.0%	18.1%	$46.3M	14.8%	37.2%	29.9%	−$44.2M	−0.3x	$39.7M	−0.0%	4	$0.0M	$13.3M
Septerna, Inc.SEPN	Pharmaceutical Preparations	$2.0B	$44.14	6.7%	$46.0M	4,174.5%	−148.6%	—	—	—	−106.4%	$110M	238.7%	—	−12.2%	—	—	—	347.5%	4	$0.0M	$40.6M
Solaredge Technologies, Inc.SEDG	Semiconductors & Related Devices	$2.0B	$32.16	1.6%	$1.2B	31.4%	−25.5%	—	−4.1%	16.6%	−34.2%	$80.8M	6.8%	—	−74.7%	—	—	$0.0M	3.3%	6	$0.0M	$0.0M
Nayax Ltd.NYAX	Services-Prepackaged Software	$2.0B	$51.92	3.0%	$400M	27.5%	9.4%	55.1x	38.4%	48.2%	8.9%	$35.0M	8.7%	16.7%	17.9%	−$5.5M	−0.1x	—	5.3%	6	$9.0M	$0.2M
Marqeta, Inc.MQ	Services-Prepackaged Software	$1.9B	$18.04	1.6%	$625M	23.3%	−7.4%	—	16.6%	70.0%	−2.2%	$161M	25.7%	—	−1.5%	—	—	$391M	−10.9%	5	$0.0M	$0.1M
Pagaya Technologies Ltd.PGY	Finance Services	$1.9B	$19.77	4.7%	$1.3B	26.1%	20.3%	14.1x	—	42.4%	6.3%	$225M	17.3%	—	20.2%	—	—	—	17.2%	6	$0.0M	$2.2M
Soundhound Ai, Inc.SOUN	Services-Prepackaged Software	$1.9B	$4.37	3.1%	$169M	99.4%	−13.8%	—	—	42.4%	−8.3%	−$99.1M	−58.7%	—	−4.3%	—	—	—	21.0%	3	$0.0M	$1.8M
Palvella Therapeutics, Inc.PVLA	Pharmaceutical Preparations	$1.9B	$132.91	5.3%	$2.6M	303.4%	−1,490.4%	—	−38.5%	—	−1,610.6%	—	—	—	−92.1%	—	—	—	405.5%	2	$0.0M	$9.6M
Progress Software Corp /MaPRGS	Services-Prepackaged Software	$1.9B	$45.25	2.3%	$978M	29.8%	15.7%	20.9x	17.2%	80.8%	7.5%	$229M	23.5%	7.7%	15.9%	$1.3B	8.2x	$106M	−0.9%	7	$0.0M	$0.4M
GeneDx Holdings Corp.WGS	Services-Health Services	$1.9B	$62.74	2.4%	$428M	40.0%	−3.1%	—	19.0%	69.7%	−4.9%	$14.3M	3.3%	−5.4%	−7.6%	−$98.9M	—	—	6.5%	6	$0.0M	$1.8M
German American Bancorp, Inc.GABC	State Commercial Banks	$1.8B	$49.20	3.7%	$487M	37.8%	—	12.9x	18.4%	—	23.1%	$154M	31.6%	—	12.0%	−$16.2M	—	$43.3M	24.1%	6	$0.1M	$0.0M
Pdf Solutions IncPDFS	Services-Prepackaged Software	$1.8B	$44.23	8.4%	$219M	22.0%	2.7%	176.9x	20.0%	72.3%	−0.3%	−$8.6M	−3.9%	1.3%	−0.2%	$24.8M	2.5x	$0.2M	0.7%	3	$0.0M	$0.2M
Astrana HealthASTH	Health Care Facilities	$1.8B	$36.94	0.8%	$3.2B	56.4%	2.5%	44.5x	35.9%	—	0.7%	$104M	3.3%	4.2%	3.0%	$609M	4.9x	$33.5M	2.9%	4	$0.0M	$0.0M
Armour Residential REIT, Inc.ARR	Real Estate Investment Trusts	$1.8B	$12.65	0.2%	$158M	490.8%	—	23.4x	8.3%	—	203.8%	—	—	—	17.8%	—	—	$303M	80.7%	—	$0.0M	$0.6M
Xeris Biopharma Holdings, Inc.XERS	Pharmaceutical Preparations	$1.8B	$10.45	2.4%	$292M	43.7%	8.5%	—	70.2%	—	0.2%	—	—	20.2%	—	$109M	4.2x	—	17.7%	7	$0.0M	$1.2M
Rush Street InteractiveRSI	Casinos & Gaming	$1.8B	$15.41	5.5%	$1.1B	22.8%	7.7%	—	32.4%	34.6%	2.9%	$164M	14.5%	—	29.5%	—	—	$7.6M	167.1%	—	$0.0M	$12.3M
Mach Natural Resources LpMNR	Crude Petroleum & Natural Gas	$1.8B	$10.62	0.5%	$1.2B	21.2%	20.8%	19.0x	—	—	12.2%	—	—	—	—	$1.1B	2.0x	—	34.6%	5	$2.4M	$0.0M
Kestra Medical Technologies, Ltd.KMTS	Surgical & Medical Instruments & Apparatus	$1.8B	$29.99	1.9%	$95.1M	59.0%	−141.6%	—	—	51.4%	−138.4%	−$117M	−122.6%	−100.5%	−56.6%	−$154M	—	—	120.4%	5	$0.0M	$9.2M
Alignment HealthcareALHC	Health Care Services	$1.7B	$8.05	2.0%	$3.9B	46.1%	0.4%	42.4x	32.7%	—	−0.0%	$113M	2.9%	—	−0.5%	−$281M	−6.2x	$0.0M	3.8%	5	$0.0M	$13.7M
Stoke Therapeutics, Inc.STOK	Pharmaceutical Preparations	$1.7B	$26.13	2.6%	$184M	404.5%	−11.2%	—	—	—	−3.7%	$44.9M	24.4%	—	−2.4%	—	—	—	9.6%	4	$0.0M	$1.1M
Zenas BioPharma, Inc.ZBIO	Pharmaceutical Preparations	$1.7B	$27.30	0.2%	$10.0M	100.0%	−3,830.6%	—	—	—	−3,777.4%	−$172M	−1,723.5%	—	−136.2%	−$265M	—	—	238.9%	2	$0.0M	$0.0M
Ultragenyx Pharmaceutical Inc.RARE	Pharmaceutical Preparations	$1.7B	$16.75	4.2%	$673M	20.2%	−79.5%	—	19.9%	—	−85.4%	−$472M	−70.1%	—	−657.1%	—	—	—	9.0%	4	$0.0M	$0.3M
Mesoblast LtdMESO	Biological Products, (No Diagnostic Substances)	$1.7B	$13.18	6.4%	$120M	599.2%	—	—	74.5%	86.1%	−47.8%	−$44.7M	−37.1%	—	−9.9%	$16.3M	—	—	7.2%	6	$0.0M	$0.0M
Alphatec Holdings, Inc.ATEC	Surgical & Medical Instruments & Apparatus	$1.7B	$10.87	0.3%	$764M	25.0%	−10.7%	—	39.5%	69.6%	−18.8%	$2.8M	0.4%	−13.5%	—	$470M	—	—	5.0%	5	$1.0M	$0.1M
Atlanticus Holdings CorpATLC	Personal Credit Institutions	$1.7B	$88.28	1.0%	$2.0B	50.1%	—	11.5x	28.4%	91.8%	6.2%	—	—	—	22.2%	—	—	$69.6M	2.0%	4	$0.0M	$0.0M
Happen, Inc.HAPN	Personal Credit Institutions	$1.7B	$14.32	4.0%	$999M	26.9%	—	8.6x	26.0%	—	13.6%	−$2.9B	−287.1%	—	9.5%	−$930M	—	—	3.6%	3	$0.0M	$3.7M
Eton Pharmaceuticals, Inc.ETON	Pharmaceutical Preparations	$1.7B	$51.16	2.0%	$80.0M	104.9%	−1.1%	—	359.6%	53.5%	−5.8%	$10.2M	12.7%	−1.7%	−18.2%	$13.4M	4.2x	—	—	4	$0.0M	$10.9M
Opera LtdOPRA	Services-Prepackaged Software	$1.7B	$18.36	3.8%	$615M	27.9%	14.7%	15.4x	30.1%	—	17.6%	$112M	18.2%	—	11.1%	—	—	$71.2M	1.4%	6	$0.0M	$0.0M
ConnectOne Bancorp, Inc.CNOB	State Commercial Banks	$1.7B	$32.99	0.5%	$388M	47.1%	—	10.8x	9.0%	—	20.7%	$101M	26.0%	—	5.7%	—	—	$32.0M	18.0%	—	$0.0M	$0.0M

What do these columns mean?

Market cap: Last close times the latest diluted share count, so it is approximate.
Price: Closing share price on the last trading day.
Day change: Change in the closing price against the previous trading day's close.
Revenue: Total sales reported in the income statement.
Revenue growth: Change in revenue against the year (or quarter) a year earlier.
Operating margin: Operating income as a share of revenue.
P/E: Last close divided by diluted earnings per share over the last four quarters.
5-yr growth: Revenue growth a year, compounded over the last five years.
Gross margin: Gross profit as a share of revenue.
Net margin: Net income as a share of revenue.
Free cash flow: Cash from operations minus capital spending.
FCF margin: Free cash flow as a share of revenue.
Return on capital: After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Return on equity: Net income as a share of average shareholders' equity.
Net debt: Debt and finance leases minus cash and short-term investments. Negative means net cash.
Net debt / EBITDA: Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
Dividends + buybacks: Cash returned to shareholders through dividends and share repurchases.
Share count change: Change in the diluted share count. Negative means buybacks shrank it.
F-score: Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
Industry: The industry the company reports under, from its SEC filing code. Click it to see its peers.
Colours and dashes: Green is up or growing, red is down or shrinking. — means no data, or a P/E that is not meaningful (losses, or above 200).
Units: M = millions, B = billions, T = trillions, in USD. Fundamentals use the latest fiscal year. Use “Edit columns” to show more figures, hide some or change their order.